nimodipine capsule liquid filled

INDICATIONS AND USAGE Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).

american health packaging

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] gynaecomastia` `[3] dyspnoea` `[4] off label use` `[5] toxicity to various agents` `[6] headache` `[7] death` `[8] completed suicide` `[9] nausea` `[10] diarrhoea`

2 years ago

OVAL GREY A297

HOW SUPPLIED Nimodipine capsules 30 mg are clear yellow solution filled in oblong gray opaque colored softgel capsules, laser imprinted “A297”. The capsules are available in the following: Unit dose packages of 20 (5 x 4) NDC 68084-912-32 Unit dose packages of 100 (25 x 4) NDC 68084-912-31 Storage: The capsules should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. capsules should be protected from light and freezing. FOR YOUR PROTECTION: Do not use if blister is torn or broken. PACKAGING INFORMATION American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Ascend Laboratories LLC as follows: (30 mg / 20 UD) NDC 68084-912-32 packaged from NDC 67877-297 (30 mg / 100 UD) NDC 68084-912-31 packaged from NDC 67877-297 Distributed by: American Health Packaging Columbus, OH 43217 8291232/0618

More pills like OVAL A297

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

nimodipine capsule liquid filled

FDA Reported Adverse Reactions [1] drug ineffective [2] gynaecomastia [3] dyspnoea [4] off label use [5] toxicity to various agents [6] headache [7] death [8] completed suicide [9] nausea [10] diarrhoea

OVAL GREY A297

More pills like OVAL A297

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] gynaecomastia` `[3] dyspnoea` `[4] off label use` `[5] toxicity to various agents` `[6] headache` `[7] death` `[8] completed suicide` `[9] nausea` `[10] diarrhoea`